|
IAC Express 2007 |
| Issue number 690: October 29, 2007 |
| |
Contents
of this Issue
Select a title to jump to the article. |
- Fatal
case of human rabies reported in Minnesota
- How's
your state doing? Data tables and maps of 2006 NIS childhood immunization
rates make it easy to find out
- VISs for
injectable influenza vaccine and Tdap vaccine now available in several
additional languages
- Error
corrected in December 2006 recommendations for eliminating hepatitis B
transmission in adults
- CDC
launches its redesigned Spanish-language website, "CDC en Espanol"
- October
25 issue of IAC's Hep Express electronic newsletter now online
- October
issue of CDC's Immunization Works electronic newsletter available on CDC
website
- CDC's
Seasonal Flu web section posts updated materials
- WHO
reports that projected production of pandemic influenza vaccine has
increased significantly
- FDA, NIH,
and WHO plan public workshop on pandemic influenza vaccine development for
December 10-11
- Draft of
pandemic influenza vaccine allocation plan now online; public comment will
be sought
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 690: October 29, 2007 |
|
|
|
1. |
Fatal case of human rabies
reported in Minnesota
On October 23, the Minnesota
Department of Health (MDH) issued a
press release reporting the death of a Minnesota man from rabies
on October 20. The death underscores the importance of
healthcare professionals educating patients about (1) the danger
bats pose as rabies carriers and (2) the efficacy of rabies
postexposure prophylaxis (PEP), when initiated immediately after
bat contact or suspected bat contact.
Portions of the MDH press release are reprinted below.
STATE REPORTS RARE DEATH FROM HUMAN RABIES
Only four other cases reported in Minnesota in the past century
Minnesota's second case of human rabies in seven years has
prompted state health officials to remind Minnesota residents to
seek immediate medical attention if they have had contact with a
bat. A man in his 40s who was exposed to a bat in north-central
Minnesota in mid-August died Saturday, October 20, the Minnesota
Department of Health (MDH) reported today.
Officials at MDH believe the man was infected with the rabies
virus after being bitten by a bat sometime in mid-August;
although he reportedly felt a "needle-prick," he did not believe
he was bitten because no blood was drawn. He did not seek
medical care immediately following the incident.
The diagnosis of rabies was confirmed Thursday, October 18,
based on testing done by the Centers for Disease Control and
Prevention (CDC) in Atlanta. . . . .
The number of rabies-related human deaths in the U.S. has
declined from more than 100 annually in the early 1900s to one
to three per year more recently. Modern day prophylaxis has
proven nearly 100 percent effective at preventing the disease.
However, treatment must be started before symptoms of rabies
appear; once a person develops symptoms, the illness is almost
always fatal. . . .
People who may have been exposed to the rabies virus are given
an injection of rabies immune globulin, and five doses of rabies
vaccine over a one-month period. Treatment is unnecessary if the
suspect animal can be captured, tested, and found to be free of
the virus. . . .
To access the complete press release, go to:
http://www.health.state.mn.us/news/pressrel/rabies102307.html
To access the document "Human Rabies Prevention--United States,
1999: Recommendations of the Advisory Committee on Immunization
Practices (ACIP)," go to:
http://www.cdc.gov/mmwr/PDF/rr/rr4801.PDF
Back to top |
| |
|
|
2. |
How's your state doing? Data tables and maps of 2006 NIS childhood
immunization rates make it easy to find out
The CDC website recently posted
2006 National Immunization
Survey (NIS) data tables and maps that show estimated
immunization rates by state for various childhood vaccines and
vaccine series. The data tables present data in two ways for
each state and local area--in the aggregate and by race and
ethnicity. Maps are color coded, with each state's color
indicating the immunization rate the state has achieved for a
given vaccine or vaccine series.
To access the data tables and maps, go to:
http://www.cdc.gov/vaccines/stats-surv/nis/figures/2006_map.htm
Click on the vaccine or vaccine series to be taken to the
pertinent data table; click on the word "map" to be taken to the
pertinent U.S. map.
Back to top |
| |
|
|
3. |
VISs for injectable influenza vaccine and Tdap vaccine now available in
several additional languages
The current version (dated
7/16/07) of the VIS for trivalent
inactivated influenza vaccine (TIV; injectable) is now available
on the IAC website in Hmong, Russian, and Somali. Dated 7/12/06,
the current VIS for tetanus-diphtheria-acellular pertussis
(Tdap) vaccine is now available in Bengali, Chinese, Haitian
Creole, Korean, Russian, and Urdu. IAC gratefully acknowledges
the Minnesota Department of Health for the TIV translations and
the New York City Department of Education and the New York City
Department of Health and Mental Hygiene for the Tdap
translations.
VISs FOR TIV VACCINE
To obtain a ready-to-print (PDF) version of the VIS for TIV
vaccine in Hmong, go to:
http://www.immunize.org/vis/hm_flu04.pdf
To obtain the VIS for TIV in Russian, go to:
http://www.immunize.org/vis/ru_flu05.pdf
To obtain the VIS for TIV in Somali, go to:
http://www.immunize.org/vis/so_flu05.pdf
To obtain the VIS for TIV in English, go to:
http://www.immunize.org/vis/2flu.pdf
VISs FOR Tdap VACCINE
To obtain a ready-to-print (PDF) version of the VIS for Tdap
vaccine in Bengali, go to:
http://www.immunize.org/vis/be_tdap.pdf
To obtain the VIS for Tdap vaccine in Chinese, go to:
http://www.immunize.org/vis/ch_tdap.pdf
To obtain the VIS for Tdap vaccine in Haitian Creole, go to:
http://www.immunize.org/vis/ha_tdap.pdf
To obtain the VIS for Tdap vaccine in Korean, go to:
http://www.immunize.org/vis/ko_tdap.pdf
To obtain the VIS for Tdap vaccine in Russian, go to:
http://www.immunize.org/vis/ru_tdap.pdf
To obtain the VIS for Tdap vaccine in Urdu, go to:
http://www.immunize.org/vis/ur_tdap.pdf
To obtain the VIS for Tdap vaccine in English, go to:
http://www.immunize.org/vis/tdap.pdf
For information about the use of VISs, and for VISs in more than
30 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
| |
|
|
4. |
Error corrected in December 2006 recommendations for eliminating hepatitis B
transmission in adults
CDC published "Erratum: Vol. 55,
No. RR-16" in the October 26
issue of MMWR. It concerns an error that appeared in the MMWR
Recommendations and Reports titled "A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus
Infection in the United States: Recommendations of the Advisory
Committee on Immunization Practices (ACIP), Part II:
Immunization of Adults," which was published December 8, 2006.
The erratum is reprinted below in its entirety.
In the MMWR Recommendations and Reports "A Comprehensive
Immunization Strategy to Eliminate Transmission of Hepatitis B
Virus Infection in the United States: Recommendations of the
Advisory Committee on Immunization Practices (ACIP), Part II:
Immunization of Adults," an error occurred. In Appendix A, page
28, second column, line 10, the sentence should read, "However,
long-term protection has been demonstrated only for persons who
have completed a licensed vaccination series and have ever had
an anti-HBs concentration of >=10 mIU/mL; persons with an anti-HBs-positive result but who did not complete a vaccine schedule
might not have long-term protection from HBV infection."
To access a web-text (HTML) version of the erratum, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5642a7.htm
To access a ready-to-print (PDF) version of "A Comprehensive
Immunization Strategy to Eliminate Transmission of Hepatitis B
Virus Infection in the United States: Recommendations of the
Advisory Committee on Immunization Practices (ACIP), Part II:
Immunization of Adults," go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5516.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
| |
|
|
5. |
CDC launches its redesigned Spanish-language website, "CDC en Espanol"
On October 19, CDC announced the
launch of its redesigned
Spanish-language website, "CDC en Espanol." As was done with
CDC's English-language website, the Spanish website was
redesigned with a more user-friendly layout and a more powerful
search engine.
"CDC en Espanol" provides Hispanic communities with information
on a range of health promotion and disease prevention topics,
including immunization. The site receives more than 6 million
visitors a year, and its weekly distribution list has grown to
almost 6,000 members in over 40 countries around the world.
To access "CDC en Espanol," go to:
http://www.cdc.gov/spanish
Back to top |
| |
|
|
6. |
October 25 issue of IAC's Hep Express electronic newsletter now online
The October 25 issue of Hep
Express, an electronic newsletter
published by IAC, is now available online. It is intended for
health professionals, program planners, and advocates involved
in prevention, screening, and treatment of viral hepatitis.
IAC Express has already covered some of the information
presented in the October 25 Hep Express; titles of articles we
have not yet covered follow.
-
CDC posts hepatitis A Q&As for healthcare professionals
-
CDC releases National Immunization Survey data on hepatitis B
birth dose
-
HBF [Hepatitis B Foundation] posts fall 2007 issue of "B
Informed" newsletter on its website
-
Journal articles you may have
missed
To access the October 25 issue, go to:
http://www.hepprograms.org/hepexpress/issue63.asp
To sign up for a free subscription to Hep Express, go to:
http://www.immunize.org/subscribe
To access previous issues of Hep Express, go to:
http://www.hepprograms.org/hepexpress
Back to top |
| |
|
|
7. |
October issue of CDC's Immunization Works electronic newsletter available on
CDC website
The October issue of Immunization
Works, a monthly email
newsletter published by CDC, is available on the website of the
National Center for Immunization and Respiratory Diseases
(NCIRD). The newsletter offers members of the immunization
community non-proprietary information about current topics. CDC
encourages its wide dissemination.
Some of the information in the October issue has already
appeared in previous issues of IAC Express. Following is the
text of four articles we have not covered.
MEETINGS, CONFERENCES & RESOURCES
NOMINATE ACIP MEMBERS: CDC is soliciting proposals for
nominations of candidates to fill upcoming vacancies on the
Advisory Committee on Immunization Practices (ACIP). The terms
of appointment for three of ACIP's fifteen members will expire
on June 30, 2008, and three new members will be selected to
serve 4-year terms beginning on July 1, 2008. The deadline for
receipt of applications is November 16, 2007. Consult the ACIP
Nominations page [http://www.cdc.gov/vaccines/recs/acip/req-nominate.htm] of the ACIP website for more information.
GET READY FOR NIC: The 42nd National Immunization Conference
(NIC) is now accepting abstracts. The conference will be held
from March 17–20, 2008, in Atlanta, Georgia, and comprises six
topic tracks: Adolescent and Adult Vaccination, Epidemiology and
New Vaccines, Health and Risk Communication, Immunization
Information Systems, Influenza, and Programmatic Issues. To
submit abstracts, register, or reserve your hotel room, visit
the NIC website [http://www.cdc.gov/vaccines/events/nic]. Any
questions can be addressed to the Conference Planning Team at
nipnic@cdc.gov
ON-SITE TRAINING IN ATLANTA: A two-day Epidemiology and
Prevention of Vaccine-Preventable Diseases course will be held
in Atlanta on April 15 and 16, 2008, at CDC. Course registration
and information will be posted soon at CDC's Vaccine website on
the On-site Training page
[http://www.cdc.gov/vaccines/ed/onsite-trg.htm].
UPCOMING BROADCASTS, WEBCASTS, AND NET CONFERENCES: Please mark
your calendars for the December 13, 2007 satellite broadcast
from CDC's National Center for Immunization and Respiratory
Diseases (NCIRD). More information about this broadcast and
other training opportunities can be found at the CDC Vaccine
Education and Training website
[http://www.cdc.gov/vaccines/ed/default.htm].
To access the complete October issue from CDC's Vaccines &
Immunizations website, go to:
http://www.cdc.gov/vaccines/news/newsltrs/imwrks/2007/200710.htm
Back to top |
| |
|
|
8. |
CDC's Seasonal Flu web section posts updated materials
CDC recently updated these
materials on its Seasonal Flu web
section:
-
"Antiviral Drugs and Influenza" (10/19/07)
-
"Key Facts About Influenza and Influenza Vaccine" (10/19/07)
-
"Influenza Symptoms, Protection, and What to Do if You Get
Sick" (10/19/07)
-
"Key Facts About Seasonal Flu
Vaccine" (10/19/07)
To access these resources, go to:
http://www.cdc.gov/flu/whatsnew.htm#updated and click on the
pertinent link.
To access a broad range of continually updated information on
seasonal influenza, avian influenza, pandemic influenza, and
swine influenza, go to: http://www.cdc.gov/flu
Back to top |
| |
|
|
9. |
WHO
reports that projected production of pandemic influenza vaccine has increased
significantly
On October 23, the World Health
Organization (WHO) issued a
press release announcing that the projection for pandemic
influenza vaccine production has been revised upward. Portions
of the press release are reprinted below.
Recent scientific advances and increased vaccine manufacturing
capacity have prompted experts to increase their projections of
how many pandemic influenza vaccine courses can be made
available in the coming years.
Last spring, the World Health Organization (WHO) and vaccine
manufacturers said that about 100 million courses of pandemic
influenza vaccine based on the H5N1 avian influenza strain could
be produced immediately with standard technology. Experts now
anticipate that global production capacity will rise to 4.5
billion pandemic immunization courses per year in 2010.
"With influenza vaccine production capacity on the rise, we are
beginning to be in a much better position vis-a-vis the threat
of an influenza pandemic," Dr. Marie-Paule Kieny, director of
the Initiative for Vaccine Research at WHO, said today.
"However, although this is significant progress, it is still far
from the 6.7 billion immunization courses that would be needed
in a six-month period to protect the whole world.
"Accelerated preparedness activities must continue, backed
by political impetus and financial support, to further
bridge the still substantial gap between supply and demand,"
she said. . . .
To access the complete press release, go to:
http://www.who.int/mediacentre/news/releases/2007/pr60/en
Back to top |
| |
|
|
10. |
FDA, NIH, and WHO plan public workshop on pandemic influenza vaccine
development for December 10-11
FDA, in cooperation with the
National Institutes of Health and
the World Health Organization, is holding a public workshop,
"Immune Correlates of Protection Against Influenza A Viruses in
Support of Pandemic Vaccine Development." It is planned for
December 10-11 in Bethesda, MD.
The workshop will include discussions on (1) current knowledge
regarding correlates of protection against seasonal influenza,
(2) immune responses to avian influenza infections and vaccines
for novel influenza viruses in humans, (3) assays to evaluate
vaccine immunogenicity, and (4) evaluation of avian influenza
vaccine efficacy.
The registration deadline is November 19. Early registration is
recommended because seating is limited. There will be no on-site
registration. For a registration form, go to:
http://www.fda.gov/cber/meetings/panflu121007reg.pdf
For additional information, contact Maureen Hess by phone at
(301) 827-5113 or by email at maureen.hess@fda.hhs.gov
Back to top |
| |
|
|
11. |
Draft of pandemic influenza vaccine allocation plan now online; public
comment will be sought
On October 23, the federal
government posted "Draft Guidance on Allocating and Targeting Pandemic
Influenza Vaccine" on the PandemicFlu website. To access the document, go to:
http://www.pandemicflu.gov/vaccine/prioritization.pdf
Comments on the draft will be sought through public meetings, stakeholder
meetings, web-based public dialog, and requests for comment posted at the
PandemicFlu website [http://www.pandemicflu.gov]
and in the Federal Register.
Back to top |
| |
|
|
